7-117590442-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_000492.4(CFTR):c.1766+3A>T variant causes a splice region, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000492.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.1766+3A>T | splice_region_variant, intron_variant | Intron 13 of 26 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cystic fibrosis Uncertain:2
The c.1766+3A>T intronic variant results from an A to T substitution 3 nucleotides after coding exon 13 in the CFTR gene. This nucleotide position is well conserved in available vertebrate species. Using two different splice site prediction tools, this alteration is predicted by ESEfinder to abolish the native splice donor site, but is predicted to weaken (but not abolish) the efficiency of the native splice donor site by BDGP; however, direct evidence is unavailable. Additional variants impacting this splice site (c.1766 historically named as c.1898), including c.1766+3A>G, c.1766+3A>C, and c.1766+5G>T, have been confirmed to cause skipping of exon 12 and have been reported in individuals with cystic fibrosis (Cremonesi L et al. Hum. Mutat., 1992;1:314-9; Zielenski et al Annu Rev Genet. 1995; 29:777-807; Kinnunen S et al. J. Cyst. Fibros., 2005 Dec;4:233-7; Dujardin G, J. Cyst. Fibros. 2011 May; 10(3):212-6; Raynal et al Hum Mutat 2013; 34(5):774-784). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at